XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Marketable Securities
3 Months Ended
Mar. 31, 2019
Investments Debt And Equity Securities [Abstract]  
Marketable Securities

NOTE 3—MARKETABLE SECURITIES

The table below summarizes the Company’s cash equivalents and available-for-sale securities (in thousands):

 

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Fair Value

 

March 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

15,233

 

 

$

 

 

$

 

 

$

15,233

 

Commercial paper securities

 

 

4,990

 

 

 

 

 

 

 

 

 

4,990

 

Total

 

 

20,223

 

 

 

 

 

 

 

 

 

20,223

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper securities

 

 

180,380

 

 

 

19

 

 

 

 

 

 

180,399

 

Corporate debt securities

 

 

70,973

 

 

 

 

 

 

(25

)

 

 

70,948

 

U.S. government-sponsored entity debt securities

 

 

18,681

 

 

 

 

 

 

 

 

 

18,681

 

Total

 

 

270,034

 

 

 

19

 

 

 

(25

)

 

 

270,028

 

Total cash equivalents and available-for-sale securities

 

$

290,257

 

 

$

19

 

 

$

(25

)

 

$

290,251

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

103,291

 

 

$

 

 

$

 

 

$

103,291

 

Total

 

 

103,291

 

 

 

 

 

 

 

 

 

103,291

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper securities

 

 

177,353

 

 

 

 

 

 

(129

)

 

 

177,224

 

Corporate debt securities

 

 

63,981

 

 

 

 

 

 

(111

)

 

 

63,870

 

U.S. government-sponsored entity debt securities

 

 

18,640

 

 

 

 

 

 

(19

)

 

 

18,621

 

Total

 

 

259,974

 

 

 

 

 

 

(259

)

 

 

259,715

 

Total cash equivalents and available-for-sale securities

 

$

363,265

 

 

 

 

 

$

(259

)

 

$

363,006

 

 

As of March 31, 2019 and December 31, 2018, all of the Company’s investments had maturity dates within one year as of the balance sheet date.  The Company had no material realized losses of its available-for-sale securities for the three months ended March 31, 2019 or 2018.  Sangamo has the intent and ability to hold its investments for a period of time sufficient to allow for any anticipated recovery in market value.  No investments were other-than-temporarily impaired at either March 31, 2019 or December 31, 2018.